Quick verdict
Henry Meds is the better pick for most patients on overall scoring. Henry built the cash-pay compounded GLP-1 category and still runs the cleanest version of it. Flat monthly pricing, no labs theater, true month-to-month. Pivoted hard after the FDA shortage delisting and now leans on personalization-claim 503A pharmacies.
That said, Hims & Hers wins on specific dimensions. Same-day prescription, no lock-in, and brand-name confidence. The famous $199 compounded era ended in March 2026 after the Novo Nordisk settlement; new patients now route to branded products only.
Side-by-side
| Hims & Hers | Henry Meds | |
|---|---|---|
| Starts from | $199/mo (incl. medication) | $297/mo (incl. medication) |
| Lock-in | Month-to-month | Month-to-month |
| Time to prescription | 1 day | 2 days |
| Consultation type | Asynchronous | Asynchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Hims & Hers | Henry Meds | |
|---|---|---|
| Pricing transparency | 7/10 | 8/10 |
| Cancellation terms | 9/10 | 9/10 |
| Onboarding experience | 9/10 | 8/10 |
| Medication options | 7/10 | 6/10 |
| Member outcomes | 5/10 | 7/10 |
When to choose Hims & Hers
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable all-in monthly pricing.
When to choose Henry Meds
Buyers who want predictable flat-rate compounded semaglutide with no commitments and minimal friction.
FAQ
Is Hims & Hers cheaper than Henry Meds?
Can I switch from Hims & Hers to Henry Meds mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →